Technical Analysis for INMB - INmune Bio Inc.

Grade Last Price % Change Price Change
D 11.02 -0.36% -0.04
INMB closed down 0.36 percent on Monday, March 18, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Doji - Bullish? Reversal 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -0.36%
Oversold Stochastic Weakness -0.36%
MACD Bearish Centerline Cross Bearish -6.29%
NR7 Range Contraction -6.29%
NR7-2 Range Contraction -6.29%
Inside Day Range Contraction -6.29%

   Recent Intraday Alerts

Alert Time
Lower Bollinger Band Support about 13 hours ago
60 Minute Opening Range Breakdown about 13 hours ago
Fell Below Previous Day's Low about 13 hours ago
Down 1% about 13 hours ago
Possible Inside Day about 14 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

INmune Bio, Inc. is a clinical-stage biotechnology company developing therapies targeting the innate immune system in cancer. INmune Bio is developing two products platforms that reengineer the patient’s innate immune system’s response to their cancer, INKmune and INB03. INKmune is a Natural Killer (NK) cell therapeutic that primes the patient’s NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells (MDSC), which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio’s product platforms target residual disease and utilize a precision medicine approach for treatment of a wide variety of hematologic malignancies and solid tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Disease Solid Tumors Immune System Immunotherapy Cancer Treatment Precision Medicine Hematologic Malignancies Checkpoint Inhibitor Tumors Of The Hematopoietic And Lymphoid Tissues Residual Disease

Is INMB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.74
52 Week Low 5.87
Average Volume 79,889
200-Day Moving Average 9.39
50-Day Moving Average 12.18
20-Day Moving Average 12.20
10-Day Moving Average 11.83
Average True Range 0.84
RSI (14) 40.12
ADX 13.4
+DI 15.83
-DI 24.75
Chandelier Exit (Long, 3 ATRs) 11.97
Chandelier Exit (Short, 3 ATRs) 13.31
Upper Bollinger Bands 13.50
Lower Bollinger Band 10.89
Percent B (%b) 0.05
BandWidth 21.42
MACD Line -0.25
MACD Signal Line -0.06
MACD Histogram -0.1867
Fundamentals Value
Market Cap 198.6 Million
Num Shares 18 Million
EPS -1.52
Price-to-Earnings (P/E) Ratio -7.25
Price-to-Sales 971.08
Price-to-Book 4.86
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.12
Resistance 3 (R3) 12.16 11.84 11.93
Resistance 2 (R2) 11.84 11.56 11.82 11.87
Resistance 1 (R1) 11.43 11.39 11.27 11.39 11.81
Pivot Point 11.11 11.11 11.03 11.09 11.11
Support 1 (S1) 10.70 10.83 10.54 10.66 10.23
Support 2 (S2) 10.38 10.66 10.36 10.17
Support 3 (S3) 9.97 10.38 10.11
Support 4 (S4) 9.93